Inflammation Research

, Volume 62, Issue 7, pp 653–657 | Cite as

Therapeutic potential of targeting inflammation

Meeting Report


Rheumatoid Arthritis Periodontitis Inflammation Research Pulmonary Alveolar Proteinosis Industrial Researcher 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



I thank all presenters at the Summit for their contribution and to those who have contributed to the fruitful discussions. Elisabeth Peen is also thanked for comments on this report. The Summit was organized by Ian Ahnfelt-Rønne, Lisa Marshall, Kouji Matsushima, Elisabeth Peen and John Hamilton. We thank the following sponsors: Abbott, Abide Therapeutics, Biogen Idec, Celgene, Chugai Pharmaceutical Co., Ltd, GlaxoSmithKline, Janssen, Kyowa-Hakko-Kirin Co. Ltd, MedImmune, Novo Nordisk, Pfizer Inc., Roche Group and Regeneron Pharmaceuticals. A full report of the Summit and cited literature can be viewed on the IAIS website

Conflict of interest

The author declares no competing financial interests.

Supplementary material

11_2013_614_MOESM1_ESM.docx (21 kb)
Supplementary material 1 (DOCX 20 kb)

Copyright information

© Springer Basel 2013

Authors and Affiliations

  1. 1.University of Melbourne, Department of Medicine, The Royal Melbourne HospitalParkvilleAustralia

Personalised recommendations